Lv3
240 积分 2024-04-07 加入
Neoadjuvant palbociclib plus either giredestrant or anastrozole in oestrogen receptor-positive, HER2-negative, early breast cancer (coopERA Breast Cancer): an open-label, randomised, controlled, phase 2 study
12天前
已完结
The winding road: Infectious disease considerations for CAR-T and other novel adoptive cellular therapies in the era of COVID-19
2个月前
已完结
Intracellular checkpoints for NK cell cancer immunotherapy
2个月前
已完结
Interfering with KIR and NKG2A immune checkpoint axes to unleash NK cell immunotherapy
2个月前
已完结
Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient
2个月前
已完结
Donor-Derived CD7 Chimeric Antigen Receptor T Cells for T-Cell Acute Lymphoblastic Leukemia: First-in-Human, Phase I Trial
3个月前
已完结
Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
3个月前
已完结
CD7 CAR T-Cell Therapy and Allogeneic HSCT
3个月前
已完结
Ex vivo expansion of the highly cytotoxic human natural killer cell line NK-92 under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy
3个月前
已完结
In vivo dendritic cell reprogramming for cancer immunotherapy
3个月前
已完结
皖公网安备34019202002308
